FUZEON

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Lithuania, Mexico, Poland, Romania, United Kingdom

Active ingredients

The drug FUZEON contains one active pharmaceutical ingredient (API):

1 Enfuvirtide UNII 19OWO1T3ZE - ENFUVIRTIDE

Enfuvirtide is a member of the therapeutic class called fusion inhibitors. It is an inhibitor of the structural rearrangement of HIV-1 gp41 and functions by specifically binding to this virus protein extracellularly thereby blocking fusion between the viral cell membrane and the target cell membrane, preventing the viral RNA from entering into the target cell. Read about Enfuvirtide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
Fuzeon 90 mg/ml powder and solvent for solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
FUZEON Powder and solvent for solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AX07	Enfuvirtide	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AX Other antivirals
Discover more medicines within J05AX07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10365M
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 529215020026002
Country: CA	Health Products and Food Branch	Identifier(s): 02247725
Country: EE	Ravimiamet	Identifier(s): 1203242, 1203253
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 03252001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 014583
Country: FR	Base de données publique des médicaments	Identifier(s): 62723129
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 79735
Country: HK	Department of Health Drug Office	Identifier(s): 57518
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1028609
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 562M2003
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100125431
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W13961002, W52557001